Raifarm registered Antigenics' anti-cancer vaccine Oncophage for the treatment of renal cell carcinoma within 9 ½ months following its submission. Russia became the first country where Oncophage has ever been registered. Oncophage also became the first ever approved anti-cancer vaccine.

Shire Human Genetic Therapies' drug for Hunter's disease treatment was registered in Russia by Raifarm in 2 ½ months through the fast-track procedure for orphan drugs.

Replagal, drug indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease, produced by Shire Corporation, was registered in Russia in 11 months.

Firazyr, drug used to treat the symptoms of attacks of hereditary angioedema in adults, developed by Jerini, was registered in Russia in 10 months.